CONTACT US
Search
Close this search box.

Articles & Videos

Australian veterans gain subsidized access to SyqeAir Inhaler

Australian veterans now have subsidised access to the SyqeAir Inhaler, following TGA approval — a major step in expanding safe, metered medical cannabis treatment through government-supported programs.

J-Wire & AJN: SyqeAir Inhaler available free to Australian veterans

SyqeAir Inhaler received the Australia’s TGA approval and included in DVA’s funding scheme — enabling eligible veterans to access the treatment at no cost.

SyqeAir Recognized as a Leading Israeli Medical Innovation

SyqeAir is making waves! We’re proud to share that Israel21c has recognized the SyqeAir Inhaler as one of the 12 most amazing Israeli medical advances.
No Camels Magazine

Rehabilitation Nation: Israeli Innovation On The Road To Healing

NoCamels News: Syqe®’s online questionnaire for self-identification of early symptoms that characterize PTSD to provide the public with an initial identification tool to promote awareness and seek immediate treatment.

EU-GMP Certification for Syqe Cartridge with Bedrocan Cannabis

An article by Bedrocan about Syqe®’s significant achievement: EU-GMP certification of the SyqeAir Cartridge containing Bedrocan’s pharmaceutical-grade cannabis – a testament to the high-quality standards maintained across the entire supply chain.

Bedrocan Spotlights Syqe’s Clinical Research on Gender Differences in Medical Cannabis Inhalation

An article by Bedrocan about Syqe®’s study showed that women and men who suffer from chronic neuropathic pain respond to medical cannabis in a similar when administered through the SyqeAir Inhaler.
Benzinga logo

‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler

An article on Benzinga highlighting the innovative SyqeAir Inhaler and its role in addressing the global challenge of cannabis overdose through metered dosing. Read what the CEO of SyqeAir, Hagit Kamin, had to say about this.
The Jerusalem Post logo

Unique Cannabis Inhaler Gives Israeli Patients a New Lease on Life

Syqe®’s groundbreaking SyqeAir Inhaler is revolutionizing medical cannabis treatment. Thus argues The Jerusalem Post, which discusses the significant impact of Syqe®’s technology on treating chronic pain and PTSD patients.

Bedrocan highlights SyqeAir’s TGA Approval in Australia

An article by Bedrocan about Syqe® receiving the Therapeutic Goods Administration (TGA) approval for the SyqeAir inhaler in Australia. This significant regulatory milestone is a step forward in the global expansion of our treatment.

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

Israeli startup Syqe® says it’s solved the problem of unpredictable and inconsistent medical cannabis treatment with the SyqeAir Inhaler and Cartridges that deliver the same dose of cannabis every time.

Does Adding CBD to THC-Rich Cannabis Reduce the Side Effects of THC? / Dr. Joshua Aviram

There are many myths and common beliefs about the THC and CBD ingredients of cannabis among the general public. Are these perceptions backed by clinical studies?

A Low Dose of Cannabis Is More Effective Than a High Dose in Relieving Pain / ynet Editorial

A clinical trial conducted by Syqe® among patients suffering from chronic pain showed that a low dose of cannabis is actually more effective in relieving pain than higher doses and causes far fewer side effects.

Myths in the Field of Medical Cannabis /
Dr. Joshua (Shuki) Aviram

Dr. Joshua (Shuki) Aviram, in an article about the myths that can be refuted in the field of medical cannabis.
The Israeli Ministry of Defense in Tel Aviv

Syqe® Medical Announces Agreement with Israeli Ministry of Defence to Provide the SyqeAir Technology to Veterans

Syqe® Medical signed a first-of-its-kind agreement with the Israeli Ministry of Defense to supply the groundbreaking SyqeAir Inhaler and Cartridges to all veterans prescribed medical cannabis.
KNOWN UNKNOWNS OF MEDICAL CANNABIS

Known Unknowns of Medical Cannabis

Volteface’s latest report examining clinician perspectives on medical cannabis points out Syqe® for developing an innovative delivery platform that provides a consistent, metered dose of medical cannabis.
SyqeAir Inhaler is distributed in Australia

Novachem offers metered-dosing inhaler to Australian patients

A metered-dose inhaler is being distributed by Novachem in Australia. Syqe® Medical, the Israeli MedTech company behind the technology claims it will “revolutionize” the delivery of medicinal cannabis.
Dr. Joshua (Shuki) Aviram, Clinical Research Director at Syqe

Real World Study Evaluates Medical Cannabis For Cancer Pain Relief

This study, which was conducted by Dr. Joshua Aviram as part of his postdoctoral fellowship, is the first to assess the possible benefits of medical cannabis for cancer-related pain in oncology patients.
Cancer Pain Treatment Using Marijuana Safe and Effective, Large Study Finds

Cancer Pain Treatment Using Marijuana Safe And Effective, Large Study Finds

Scientists have gathered evidence showing cannabis significantly improves the symptoms of cancer patients, with minimal side effects.
Study Finds Medical Cannabis Reduces Cancer Patients’ Pain And Need For Opiates

Study Finds Medical Cannabis Reduces Cancer Patients’ Pain And Need For Opiates

Researchers in Israel found that the use of medical cannabis reduced cancer patients’ pain and use of painkillers in a recently published study.
Medical cannabis shown to reduce pain in cancer patients - study

Medical Cannabis Shown To Reduce Pain In Cancer Patients – Study

The peer-reviewed study found that for most cancer patients, pain levels improved significantly and other symptoms also decreased.
Medicinal Cannabis Shown To Reduce Pain And Need For Opiate Painkillers Among Cancer Patients

Medicinal Cannabis Shown To Reduce Pain And Need For Opiate Painkillers In Cancer Patients

Most cancer patients who used medical cannabis reported a significant improvement in pain measures and a decrease in other symptoms, as well as lower consumption of opioid analgesics.
Using medical cannabis for cancer reduces painkiller usage

Using Medical Cannabis For Cancer Reduces Painkiller Usage

A new study finds that using medicinal cannabis for cancer can reduce pain and the need for opiate painkillers.
Testimonials movie for physicians

“I Wanted To Be In Control. Wanted The Pain To Go Away Without The Psychoactive Part”

SyqeAir patients talk about the treatment utilizing the medical inhaler. From the moment the doctors suggested treatment using medical cannabis till now.
Valentines Day Testimonials Campaign - Uri & Yaeli

Great Love Can Conquer The Strongest Pain – Uri & Yael

A heartwarming testimonial movie about true love, starring our patient, Uri, and his spouse, Yael. A story of love and partnership in the shadow of chronic pain.
Valentines Day Testimonials Campaign - Nelly & Guy

Great Love Can Conquer The Strongest Pain – Nelly & Guy

A heartwarming testimonial movie about true love, starring our patient, Nelly, and her spouse, Guy. A story of love and partnership in the shadow of chronic pain.
Israeli microdosing cannabis inhaler receives approval in Canada

Israeli Microdosing Cannabis Inhaler Receives Approval In Canada

The real-world data of the trials showed that patients experienced a 90% reduction in adverse effects associated with marijuana use in comparison with other methods such as oil, smoking, and vaping.

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.

Israeli Medical Cannabis Inhaler Gets Canada’s Marketing Nod

Approval is the first by an international regulator allowing the marketing of a precisely dosed cannabis inhaler as a medical product, Syqe® Medical says.
The coolest weed gadgets we’ve ever seen

The Coolest Cannabis Gadgets We’ve Ever Seen

Cannabis gadgets have come a long way. Some of them provide precision dosing, and many combine state-of-the-art design and materials with craftsmanship that (sorry) puts your old gravity bong to shame.
This Israeli Revolutionized Medical Cannabis Once. Now He’s Doing It Again

This Israeli Revolutionized Medical Cannabis Once. Now He’s Doing It Again

Perry Davidson’s Syqe® Medical has begun selling a medical cannabis inhaler that ensures that each patient is administered an exact dosage.

Eight Years And $83 Million Later, Syqe® Medical Releases First Cannabis Inhaler

Teva will market the company’s inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe® in 2016.
Syqe begins marketing medical cannabis inhaler

Syqe® Begins Marketing Medical Cannabis Inhaler

The new inhaler, which allows doctors to prescribe precise dosages, has received Ministry of Health approval in Israel.
Cannabis Inhaler Company Syqe Medical Raises $50 Million

Cannabis Inhaler Company Syqe® Medical Raises $50 Million

Syqe® develops a pocket-sized metered-dose inhaler designed for precise delivery of cannabis molecules.
How Israel's weed tech industry is taking on America's opioid crisis

How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis

America is beginning to see cannabis as an alternative to prescription pills. Israel is years ahead – and its entrepreneurs want to curb a crisis of opioid addiction that is completely out of control.
Medical Cannabis
SyqeAir Inhaler
Useful Information
Media
Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

SyqeAir logo white
The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.
Skip to content